Filing Details
- Accession Number:
- 0001209191-20-040945
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-06 14:21:47
- Reporting Period:
- 2020-07-01
- Accepted Time:
- 2020-07-06 14:21:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1515673 | Ultragenyx Pharmaceutical Inc. | RARE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1397266 | K Matthew Fust | C/O Ultragenyx Pharmaceutical Inc. 60 Leveroni Court Novato CA 94949 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-07-01 | 5,000 | $21.00 | 18,550 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-07-01 | 5,000 | $85.00 | 13,550 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-07-01 | 5,000 | $0.00 | 5,000 | $21.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 6,181 | 2024-01-29 | No | 4 | M | Direct |
Footnotes
- The exercise and sale reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- The option vested with respect to 1/36th of the shares monthly from the grant date of January 29, 2014 such that the option fully vested on the third anniversary of the grant date.
Billionaire Hedge Funds
